These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 29378480)
1. Irbesartan prevents sodium channel remodeling in a canine model of atrial fibrillation. Wang X; Li G J Renin Angiotensin Aldosterone Syst; 2018; 19(1):1470320318755269. PubMed ID: 29378480 [TBL] [Abstract][Full Text] [Related]
2. Angiotensin-(1-7) prevent atrial tachycardia induced sodium channel remodeling. Wang X; Li G Pacing Clin Electrophysiol; 2014 Oct; 37(10):1349-56. PubMed ID: 24861429 [TBL] [Abstract][Full Text] [Related]
3. Enalapril, irbesartan, and angiotensin-(1-7) prevent atrial tachycardia-induced ionic remodeling. Liu E; Xu Z; Li J; Yang S; Yang W; Li G Int J Cardiol; 2011 Feb; 146(3):364-70. PubMed ID: 19732978 [TBL] [Abstract][Full Text] [Related]
4. Effects of irbesartan on gene expression revealed by transcriptome analysis of left atrial tissue in a porcine model of acute rapid pacing in vivo. Chilukoti RK; Mostertz J; Bukowska A; Aderkast C; Felix SB; Busch M; Völker U; Goette A; Wolke C; Homuth G; Lendeckel U Int J Cardiol; 2013 Oct; 168(3):2100-8. PubMed ID: 23414741 [TBL] [Abstract][Full Text] [Related]
5. The potential role of atrial natriuretic peptide in the effects of Angiotensin-(1-7) in a chronic atrial tachycardia canine model. Zhao J; Liu T; Liu E; Li G; Qi L; Li J J Renin Angiotensin Aldosterone Syst; 2016; 17(1):1470320315627409. PubMed ID: 27009283 [TBL] [Abstract][Full Text] [Related]
6. The effects of cilazapril and valsartan on the mRNA and protein expressions of atrial calpains and atrial structural remodeling in atrial fibrillation dogs. Li Y; Li WM; Gong YT; Li BX; Liu W; Han W; Dong D; Sheng L; Xue JY; Zhang L; Chu S; Yang BF Basic Res Cardiol; 2007 May; 102(3):245-56. PubMed ID: 17268887 [TBL] [Abstract][Full Text] [Related]
7. Effect of irbesartan on development of atrial fibrosis and atrial fibrillation in a canine atrial tachycardia model with left ventricular dysfunction, association with p53. Kataoka N; Nishida K; Kinoshita K; Sakamoto T; Nakatani Y; Tsujino Y; Mizumaki K; Inoue H; Kinugawa K Heart Vessels; 2016 Dec; 31(12):2053-2060. PubMed ID: 27236656 [TBL] [Abstract][Full Text] [Related]
8. Cilostazol ameliorates atrial ionic remodeling in long-term rapid atrial pacing dogs. Zhao Z; Li W; Wang X; Chen Y; Li J; Yang W; Cheng L; Liu E; Liu T; Li G Anatol J Cardiol; 2015; 15(12):963-9. PubMed ID: 25880049 [TBL] [Abstract][Full Text] [Related]
9. Blockade of angiotensin II improves hyperthyroid induced abnormal atrial electrophysiological properties. Xiao P; Gao C; Fan J; Du H; Long Y; Yin Y Regul Pept; 2011 Aug; 169(1-3):31-8. PubMed ID: 21545815 [TBL] [Abstract][Full Text] [Related]
10. Protective effects of aliskiren on atrial ionic remodeling in a canine model of rapid atrial pacing. Zhao Z; Wang X; Li J; Yang W; Cheng L; Chen Y; Liu T; Liu E; Chen K; Li G Cardiovasc Drugs Ther; 2014 Apr; 28(2):137-43. PubMed ID: 24488001 [TBL] [Abstract][Full Text] [Related]
11. Late Sodium Current in Human Atrial Cardiomyocytes from Patients in Sinus Rhythm and Atrial Fibrillation. Poulet C; Wettwer E; Grunnet M; Jespersen T; Fabritz L; Matschke K; Knaut M; Ravens U PLoS One; 2015; 10(6):e0131432. PubMed ID: 26121051 [TBL] [Abstract][Full Text] [Related]
12. Irbesartan-mediated AT1 receptor blockade attenuates hyposmotic-induced enhancement of I Ks current and prevents shortening of action potential duration in atrial myocytes. Wu J; Ding WG; Zhao J; Zang WJ; Matsuura H; Horie M J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):341-7. PubMed ID: 23386284 [TBL] [Abstract][Full Text] [Related]
13. Relaxin suppresses atrial fibrillation in aged rats by reversing fibrosis and upregulating Na+ channels. Henry BL; Gabris B; Li Q; Martin B; Giannini M; Parikh A; Patel D; Haney J; Schwartzman DS; Shroff SG; Salama G Heart Rhythm; 2016 Apr; 13(4):983-91. PubMed ID: 26711798 [TBL] [Abstract][Full Text] [Related]
14. Study on the Effect of Irbesartan on Atrial Fibrillation Recurrence in Kumamoto: Atrial Fibrillation Suppression Trial (SILK study). Yamabe H; Kaikita K; Matsumura T; Iwasa A; Koyama J; Uemura T; Morikami Y; Tsunoda R; Morihisa K; Fujimoto K; Kajiwara I; Matsui K; Tsujita K; Ogawa H J Cardiol; 2018 Feb; 71(2):129-134. PubMed ID: 28886992 [TBL] [Abstract][Full Text] [Related]
15. Tachycardia-induced changes in Na+ current in a chronic dog model of atrial fibrillation. Gaspo R; Bosch RF; Bou-Abboud E; Nattel S Circ Res; 1997 Dec; 81(6):1045-52. PubMed ID: 9400386 [TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation. Yue L; Melnyk P; Gaspo R; Wang Z; Nattel S Circ Res; 1999 Apr; 84(7):776-84. PubMed ID: 10205145 [TBL] [Abstract][Full Text] [Related]
17. Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation. Kumagai K; Nakashima H; Urata H; Gondo N; Arakawa K; Saku K J Am Coll Cardiol; 2003 Jun; 41(12):2197-204. PubMed ID: 12821247 [TBL] [Abstract][Full Text] [Related]
18. [Effect of benazepril on atrial cytoskeleton remodeling in the canine atrial fibrillation models]. Liu L; Qu XF; Yu Y; Bai B; Huang YL Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(38):2718-21. PubMed ID: 20137276 [TBL] [Abstract][Full Text] [Related]
19. Ionic mechanisms underlying region-specific remodeling of rabbit atrial action potentials caused by intermittent burst stimulation. Dun W; Ozgen N; Hirose M; Sosunov EA; Anyukhovsky EP; Rosen MR; Boyden PA Heart Rhythm; 2007 Apr; 4(4):499-507. PubMed ID: 17399641 [TBL] [Abstract][Full Text] [Related]
20. Loss of insulin signaling may contribute to atrial fibrillation and atrial electrical remodeling in type 1 diabetes. Polina I; Jansen HJ; Li T; Moghtadaei M; Bohne LJ; Liu Y; Krishnaswamy P; Egom EE; Belke DD; Rafferty SA; Ezeani M; Gillis AM; Rose RA Proc Natl Acad Sci U S A; 2020 Apr; 117(14):7990-8000. PubMed ID: 32198206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]